Bromophenols from Symphyocladia latiuscula (Harvey) Yamada as Novel Cholecystokinin 2 Receptor Antagonists
BACKGROUND: Cholecystokinin (CCK) is one of the most abundant peptides in the central nervous system and is believed to function as a neurotransmitter as well as a gut hormone with an inverse correlation of its level to anxiety and depression. Therefore, CCK receptors (CCKRs) could be a relevant tar...
Published in: | Journal of integrative neuroscience |
---|---|
Main Authors: | Paudel P., Park S.E., Seong S.H., Fauzi F.M., Jung H.A., Choi J.S. |
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147186358&doi=10.31083%2fj.jin2201010&partnerID=40&md5=5771f2cc87d02e93480185074aeb60ba |
Similar Items
-
The high-affinity human IgG receptor Fc gamma receptor i (FcγRI) is not associated with vascular leakage of dengue
by: Zamberi Z.M.; Zakaria Z.; Aziz A.T.A.; Heng B.S.L.; Zaid M.; Chong C.L.K.; Noor F.M.; Bakar S.A.; Peng H.B.
Published: (2015) -
Antagonistic properties of potential probiotics, Lactiplantibacillus plantarum BO1 and Lacticaseibacillus paracasei BUM6 on pathogenic bacteria causing oral disease
by: Yaacob I.H.; Jafri F.A.; Sarmin N.I.M.
Published: (2024) -
Synthesis and single-molecule imaging reveal stereospecific enhancement of binding kinetics by the antitumour eEF1A antagonist SR-A3
by: Wang H.-Y.; Yang H.; Holm M.; Tom H.; Oltion K.; Al-Khdhairawi A.A.Q.; Weber J.-F.F.; Blanchard S.C.; Ruggero D.; Taunton J.
Published: (2022) -
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists
by: Zulkifly H.H.; Pastori D.; Lane D.A.; Lip G.Y.H.
Published: (2023) -
Betamethasone Dipropionate Derivatization, Biotransformation, Molecular Docking, and ADME Analysis as Glucocorticoid Receptor
by: Rashid S.; Anjum S.; Ahmad A.; Nadeem R.; Ahmed M.; Shah S.A.A.; Abdullah M.; Zia K.; Ul-Haq Z.
Published: (2022)